The National Cancer Treatment Alliance (NCTA), a nationwide network of leading, independent community oncology practices that have joined together to help employers improve cancer care, announced today the appointment of two new board members, Mark Nelson, PharmD, Chief Executive Officer at Northwest Medical Specialties and Travis Brewer, Vice President of Payer and Public Health Strategy/Relations at Texas Oncology. NCTA works directly with self-insured employers and other stakeholders to ensure their employees receive high-quality, patient-centered, and lower-cost cancer care. NCTA practices are part of a clinically integrated network (CIN) that holds them accountable for the care they provide through tracking and reporting of quality and value measures. NCTA now has 50 practices with 248 locations across 30 states.

As CEO of Northwest Medical Specialties, Mark Nelson leads organizational strategy, hospital affiliation models, finances, clinical research, business operations, and the development of novel alternative payment models. In addition, he is an active board member of the Community Oncology Alliance (COA) and the Community Oncology Pharmacy Association (COPA) and serves as an advisor to several start-up ventures in the value-based care and health care provider space. Throughout his career, Mark has assisted and advised on the development of numerous private practice affiliation models, including hospital-physician alignment strategies and private equity ventures.

Travis Brewer has over 25 years of health care administration and contracting experience from both the payer and provider sides of health care. Prior to joining Texas Oncology in 2019, he served as the senior vice president and COO for Patient Physician Network, a large multi-specialty IPA in North Texas. Previously, he was a network vice president for both United HealthCare and Aetna. He has also held leadership positions with Prudential Healthcare and HealthSouth.

“Both Mark and Travis bring decades of experience in advancing value-based care models to help community practices and pharmacies provide affordable, quality cancer care to their patients,” said Robert Baird, RN, MSA, president of NCTA. “With these new additions to our board, we are better poised than ever to achieve physician-directed, patient-centered care on a national scale.”

NCTA is working to develop direct contracts with employers and health care purchasers to provide affordable, high-quality cancer care to patients. Through this, NCTA enables providers to increase autonomy and decide with patients what is best for their treatment. Its clinically integrated network model allows providers to share best practices and connect with other independent practices, guided by quality measurements and efficient care delivery.

###

About the National Cancer Treatment Alliance (NCTA)

NCTA is a nationwide coalition of leading, independent community oncology practices that have joined together to help employers improve cancer care. The Community Oncology Alliance (COA) created NCTA to work directly with employers on cancer drugs and services, which ensures access to the highest-quality, most affordable local cancer care. NCTA leverages the expertise of its national oncology network to provide information, resources, and educational materials on key issues in cancer care to employers and employees. Find out more about NCTA at www.NCTAcancer.com.